Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer
Status:
Terminated
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the objective response rates of patients randomized
to receive either TOCOSOL(R) Paclitaxel or Taxol(R) (paclitaxel injection) administered every
week to patients with metastatic breast cancer. The study hypothesis is that the objective
response rate with TOCOSOL Paclitaxel given every week is non-inferior to that observed with
Taxol given every week.